Status: Recruiting
The iLet Experience Study
A one-year, prospective single-arm cohort study to collect safety and effectiveness data on the iLet Dosing Decision Software during real-world use in people 6 years of age or older with type 1 diabetes (T1D) with 12 months follow-up.
Participants needed: 1,875
Trial details
Age: 6+Biological sex: AllType: ObservationalSponsor: Beta Bionics, Inc.Updated: Sep 8, 2026Locations: 1Duration: 12 Months
Eligibility criteria
Diagnosed with type 1 diabetes and prescribed the iLet Bionic Pancreas System [+10]
Type 2 diabetes, cystic fibrosis-related diabetes, congenital hyperinsulinism, p... [+3]